149 related articles for article (PubMed ID: 34681106)
1. Deciphering the Molecular Machinery-Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer Cells.
Tsaur I; Thomas A; Juengel E; Maxeiner S; Grein T; Le QC; Muschta V; Rutz J; Chun FKH; Blaheta RA
Biology (Basel); 2021 Oct; 10(10):. PubMed ID: 34681106
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
4. CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro.
Tsaur I; Rutz J; Makarević J; Juengel E; Gust KM; Borgmann H; Schilling D; Nelson K; Haferkamp A; Bartsch G; Blaheta RA
World J Urol; 2015 Jul; 33(7):1051-6. PubMed ID: 25179012
[TBL] [Abstract][Full Text] [Related]
5. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.
Tsaur I; Makarević J; Juengel E; Gasser M; Waaga-Gasser AM; Kurosch M; Reiter M; Wedel S; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Br J Cancer; 2012 Aug; 107(5):847-55. PubMed ID: 22782340
[TBL] [Abstract][Full Text] [Related]
6. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
7. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
9. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
Mani J; Neuschäfer J; Resch C; Rutz J; Maxeiner S; Roos F; Chun FK; Juengel E; Blaheta RA
Nutr Cancer; 2020; 72(3):528-537. PubMed ID: 31298931
[TBL] [Abstract][Full Text] [Related]
10. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins.
Klominek J; Sumitran Karuppan S; Hauzenberger D
Int J Cancer; 1997 Sep; 72(6):1034-44. PubMed ID: 9378538
[TBL] [Abstract][Full Text] [Related]
11. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
[TBL] [Abstract][Full Text] [Related]
12. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
Laidler P; Gil D; Pituch-Noworolska A; Ciołczyk D; Ksiazek D; Przybyło M; Lityńska A
Acta Biochim Pol; 2000; 47(4):1159-70. PubMed ID: 11996105
[TBL] [Abstract][Full Text] [Related]
13. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions.
Juengel E; Meyer dos Santos S; Schneider T; Makarevic J; Hudak L; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Exp Biol Med (Maywood); 2013 Nov; 238(11):1297-304. PubMed ID: 24006305
[TBL] [Abstract][Full Text] [Related]
15. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.
Lee YC; Jin JK; Cheng CJ; Huang CF; Song JH; Huang M; Brown WS; Zhang S; Yu-Lee LY; Yeh ET; McIntyre BW; Logothetis CJ; Gallick GE; Lin SH
Mol Cancer Res; 2013 Apr; 11(4):405-17. PubMed ID: 23339185
[TBL] [Abstract][Full Text] [Related]
16. IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction.
Chen C; Zhang Q; Liu S; Parajuli KR; Qu Y; Mei J; Chen Z; Zhang H; Khismatullin DB; You Z
Prostate; 2015 Jun; 75(8):883-95. PubMed ID: 25683512
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells.
Muñoz-Moreno L; Bajo AM; Prieto JC; Carmena MJ
Mol Cell Endocrinol; 2017 May; 446():59-69. PubMed ID: 28193499
[TBL] [Abstract][Full Text] [Related]
18. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.
Jin JK; Tien PC; Cheng CJ; Song JH; Huang C; Lin SH; Gallick GE
Oncogene; 2015 Apr; 34(14):1811-21. PubMed ID: 24793790
[TBL] [Abstract][Full Text] [Related]
19. Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane.
Dedhar S; Saulnier R; Nagle R; Overall CM
Clin Exp Metastasis; 1993 Sep; 11(5):391-400. PubMed ID: 8375114
[TBL] [Abstract][Full Text] [Related]
20. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
Furbert-Harris PM; Parish-Gause D; Hunter KA; Vaughn TR; Howland C; Okomo-Awich J; Forrest K; Laniyan I; Abdelnaby A; Oredipe OA
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1009-16. PubMed ID: 14682382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
